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Introduction
As a pathological basis of cardiovascular disease (CVD), atherosclerosis is characterized as a complex multi-factorial process that shows the accumulation of lipids and fibrous elements in arterial walls.
Atherosclerosis could be worsened by behavioral risk factors such as cigarette smoking, poor quality diet, physical inactivity, excessive alcohol consumption and obesity. Conversely, healthy lifestyles were considered that could be beneficial for CVD (Millen et al. 2014) . Dietary restriction (DR) has been found to extend life in various species. Although there is still controversy about the effect of DR on mammals, some studies have proven that DR can directly ameliorate atherosclerotic progression in rodents and human (Guo et al. 2002; Fontana et al. 2004; Hursting et al. 2010; Dolinsky and Dyck 2011) . Interestingly, given a large number of patients who are subjected to lipid-lowering therapy, a question arises whether DR can promote the beneficial effects on blood lipid control and atherosclerotic regression. To address this question, we developed HCD-induced hypercholesterolemia in rabbits; then, dietary cholesterol withdrawal along with DR was employed to intervene these rabbits, and the effects of DR on atherosclerotic progression, lipid and glucose metabolism were observed.
Materials and methods

Experimental design
We designed this experiment as shown in Fig. 1 . 50 Japanese white rabbits were fed by a high-cholesterol diet (HCD; containing 0.3% cholesterol and 3% corn oil; approximately 120-180 g per day) for 12 weeks to develop mild atherosclerosis (Yu et al. 2012b) . HCD contains approximately 2.63 kilocalories per gram. Next, these rabbits were randomly divided into four groups, and the baseline was sacrificed immediately (n=10). Another group was continually fed by HCD in another 16 weeks as a positive control group (n=10). The rest of two groups were fed with a normal diet instead of a HCD.
Among them, the DR group (n=15) was fed by the dietary restriction and received 60% of the diet consumption in the group that was fed by ad libitum (AL, n=15) (approximately 90 g and 150-180 g per day, respectively) (Guo et al. 2002) . A normal diet is constituted by crude protein (18.5%), crude fat (2.7%), crude fiber (13.4%), ash (8.5%), carbohydrate (42%) and others (14.9%), which contains approximately 2.43 kilocalories per gram. The amount of food consumption of each rabbit was monitored by daily check and was calculated each week. This study was carried out according to the D r a f t Guidelines for Animal Experimentation of Xi'an Medical University and the Guide for the Care and Use of Experimental Animals (Vol. 1, 2nd ed., 1993, and Vol. 2, 1984, 
Assessment of plasma parameters
Plasma total cholesterol (TC), triglyceride (TG), and high density lipoprotein-cholesterol (HDL-C) were measured weekly by using commercial assay kits (BioSino Bio-technology and Science Inc, Beijing, China). Plasma glucose was measured every four weeks by using a commercial assay kit (BioSino Bio-technology and Science Inc, Beijing, China). The measurement protocols of plasma TC, TG, HDL-C and glucose were described in our previous study (Yu et al. 2012a ).
Analysis of glucose metabolism
Intravenous glucose tolerance tests (IGTT) and intravenous insulin tolerance test (IITT) were performed at the end of study as previously described (Cheng et al. 2015) . Briefly, the rabbits were injected with glucose solution intravenously after 16 h of fasting, and then blood samples were drawn at 5, 10, 15, 20, 30, 45, 60, 75 and 120 min (2 g/kg body weight). For IITT, after the intravenous injection of insulin (1 U/kg body weight; Wanbang Co., Jiangsu, China), blood samples were collected to examine blood sugar at 5, 10, 15, 30, 45, 60, 90 and 120 min, and plasma insulin was also measured at 0, 60 and 120 min by using an ELISA kit (Shibayagi Co., Gunma, Japan). The areas under carve (AUC) of IGTT and IITT were quantified according to previously described (Cheng et al. 2015) . At 0, 8, 12 and 16 weeks of dietary lipid lowering, the plasma glucagon levels of the AL and DR groups were measured by an ELISA kit (Merck Millipore Co., Billerica, MA, USA).
Histology and immunohistochemistry
After formalin fixation, the whole aortas were stained with Sudan IV and photographed for the evaluation of the gross size of atherosclerotic lesions. For histological analysis, the aortic arch of each rabbit was cut into cross 8 to 10 sections (4 µm) as previously described (Yu et al. 2014 Adipose tissue and liver were made to sections and stained with H&E, and adipocyte size was evaluated under a light microscope as previously described (Waqar et al. 2010) . All sections (H&E, EVG and immunostaining) were captured with a digital camera (Olympus Inc., Tokyo, Japan) and quantified by ImageJ as previously described .
Western blotting
Total protein was extracted from plasma and western blotting was performed as previously described (Fukuda et al. 2017 ). The primary antibody was against adiponectin (R&D systems; 1:1000). Western blotting analysis was performed as previously described, and relative protein expression was quantified by ImageJ (Gassmann et al. 2009 ).
Statistical analysis
All data are expressed as mean ± SE. Comparisons for two groups were performed by t-test.
Comparisons for multiple groups were conducted by one-way or two-way ANOVA with Bonferroni test. P<0.05 is considered as a statistically significant.
Results
Body weight, internal organs and fat mass
In 16 weeks of diet cholesterol withdrawal, the AL and DR groups consumed 150 ± 7.24 g/day or 89.35 ± 0.02 g/day of a chow diet, respectively. The DR group showed that body weights were remarkably reduced when compared with the AL group from 8 weeks to 16 weeks ( Fig. 2A) . Interestingly, the HCD-fed rabbits had the lower body weight than the AL or DR group ( Fig. 2A) . To study the weight of major internal organs, we found that both DR and HCD groups had dramatically reduced weights of liver when compared with the baseline and AL group, respectively (Fig. 2B ).
We next analyzed the distribution of adipose tissue, finding that visceral and subcutaneous adipose tissues were significantly decreased in the DR group (Fig. 3A) . Conversely, the AL group accumulated more subcutaneous fat, and the HCD group accumulated more visceral fat than the baseline group ( . Moreover, we also analyzed the adipocytes size between the AL and DR groups, indicating that the diameter of visceral adipocytes in DR-treated rabbits were dramatically reduced in a narrow range of 20-40 µm (Fig. 3B) . Considering that the small size of adipocytes may affect glucose and lipid metabolism via adipocytokines, we also measured plasma adiponectin to check the effect of DR on endocrine function of adipose tissue. As showed by a result from Western blotting, we did not find any difference between the AL and DR groups (Fig. 3C ).
DR affects glucose and insulin metabolism
By comparing the levels of fasting plasma glucose, we found that there was no obvious difference between the AL and DR groups (Fig. 4A) . We also performed IGTT and IITT to evaluate glucose intolerance and insulin sensitivity on these rabbits. We found the DR group had significantly increased blood glucose levels at last two time points in IGTT, but no difference in comparison of AUC values (Fig. 4B ). However, after intravenous injection of insulin, IITT revealed that the DR group had significantly reduced blood glucose levels at last three time points, but no difference in comparison of AUC values (Fig. 4C ).
To study the effect of DR on insulin and glucagon secretion, we measured the levels of these hormones by using a pair of commercial ELISA kits. Interestingly, DR-treated rabbits exhibited the lower plasma insulin than the AL group and reached statistical significance at 30 min after intravenous injection of glucose ( Fig. 5A ). However, we did not find any significant difference in plasma glucagon between two groups (Fig. 5B ).
DR affects dietary lipid lowering
By feeding 16 weeks of a chow diet, a declining trend of plasma TC was found in both AL and DR groups (Fig. 6A) . Notable, the DR group had relatively higher plasma TC than the AL group from 7 to 16 weeks of rabbits fed with a chow diet, and the statistical significances were achieved at the most time points during this period (p<0.05 or p<0.01 versus the AL group; Fig. 6A ). We also examined plasma HDL-C, whereas there was no difference between the AL and DR groups (Fig. 6B) . Moreover, plasma TG levels in both AL and DR groups were also slowly declining during 16 weeks of diet cholesterol withdrawal, and DR-treated rabbits showed lower plasma TG in 2 and 3 weeks than the AL group (Fig. 6C ). D r a f t
DR does not ameliorate atherosclerotic progression
To quantify of the gross lesion, The AL and DR groups showed severely atherosclerotic lesions at the end of this study ( ** p < 0.01 and *** p < 0.001 versus the baseline group, respectively; Fig. 7 ). In spite of the AL and DR-treated rabbits underwent 16 weeks of a chow diet feeding, their gross lesions still accounted for approximately 65% and 57% of the whole aorta (respectively), when contrasted to 72%
of the whole aorta in the HCD group (Fig. 7) . To explore the effect of DR on atherosclerotic progression, we also compared the gross lesions between the DR and AL groups, showing no significant difference (Fig. 7) . Given that intimal components determine the inflammation and stability in atherosclerotic lesions, we next analyzed the effect of DR on intimal lesions, macrophages and SMCs. However, we did not find any difference when compared the AL group with the DL group (Fig.   8 ).
Discussion
In this study, we intended to elucidate the effect of DR on atherosclerotic progression, lipid and glucose metabolism in the rabbits with dietary lipid lowering. After 16 weeks of DR, body weight, internal organs and fat mass were dramatically reduced in these rabbits. In light of that visceral adipose tissues play a key role for the CVD, we investigated the distribution of adipose tissue and the size of visceral adipocyte in these rabbits (Muzumdar et al. 2008) . Unlike the HCD-fed rabbits, an alternative normal diet can decrease visceral fat mass rather than subcutaneous fat mass (Yu et al. 2012c) . Furthermore, the DR causes a decrease in visceral fat mass and the size of adipocytes, which be deemed as a beneficial factor for metabolic disease (Skurk et al. 2007) . Especially for small size of adipocytes, it has been reported that improves atherosclerotic regression and lipid metabolism whereby the production of the adipocytokines (Laforest et al. 2015) . Although the current study does not support that DR promote a significant increase of plasma adiponectin, there is a possible explanation that the function of small adipocytes is suppressed by hypercholesterolemia in these animals. Interestingly, the positive control group also had reduced body weight and small internal organs in another 16 weeks of HCD-fed, which was attributed to that a long-term of HCD intake may affect rabbits' metabolism as previously described (Yu et al. 2012b; Fan et al. 2015) It has been reported that DR can improve glucose intolerance and insulin sensitivity from various D r a f t animal models to human being (Wang et al. 2011; Roth and Polotsky 2012; Pires et al. 2014) . However, when rabbits with dietary lipid lowering, a pair of paradoxical results indicated that DR slightly worsened glucose intolerance but improved insulin sensitivity. Nonetheless, in light of a large fluctuation in plasma glucose levels of rabbits, the slight changes in the results of IGTT and IITT do not mean DR contributing to significant effect on glucose metabolism. In clinical practice, the effect of DR on glucose metabolism should be carefully evaluated. Considering that DR might suppress the secretion of insulin, we used a commercial ELISA kit to check this effect, indicating that DR indeed promoted a slight reduction in plasma insulin levels after stimulated by glucose intravenous injection.
Under the hypoglycemic condition, pancreatic α cells produce glucagon to inhibit β cells for insulin secreting, and glucagon is deemed as an antagonist against the physiological effects of insulin as well (Koubova and Guarente 2003) . Accordingly, we measured the levels of plasma glucagon by another commercial ELISA kit. Despites no obvious difference in plasma glucagon, the inhibition of DR on insulin levels via paracrine suppression by glucagon still need to be further investigated.
After removed cholesterol from the diet, hypercholesterolemic rabbits presented very slowly declining in the plasma lipids during this period, which was ascribed to that excess cholesterol accumulation in extravascular site and later diffused into the blood (Khanna et al. 2013) . Of note, DR did not enhance the clearance of plasma TC. Inversely, a retardant decline of plasma TC levels in the DR-treated rabbits was observed. A previous study revealed that dietary restriction gave rise to significantly high TC in the hypercholesterolemic rabbits, and the mechanism was suggested that dietary restriction might cause inhibition of hepatic uptake, an increased production of lipoprotein, increased intestinal absorption of cholesterol and the activity of N-acetyl-β-glucosaminidase (Lacombe et al. 1983 ). Contrasted to this study, we further observed that DR increased plasma TC after dietary cholesterol withdrawal. Moreover, DR also not increased HDL-C when compared with rabbits with AL fed, which might be attributed to that DR promoted overproduction of LDL-C and VLDL-C rather than HDL-C as previously described 
D r a f t
After 12 weeks of high-cholesterol diet feeding, rabbits showed obvious gross lesions of atherosclerosis (26% of the whole aorta) as the early-and middle-stage of atherosclerotic lesions in human (Yu et al. 2012b; Fan et al. 2015) . Interestingly, despite that the AL and DR-treated rabbits underwent another 16 weeks of diet cholesterol withdrawal, they still developed more severe atherosclerosis than the baseline group. Based on this finding, we suggest that the term of HCD-fed could be shorten when rabbit model is used for the study of atherosclerosis or hypercholesterolemia. Moreover, whereby various comparisons in the gross and intimal lesions, the accumulation of macrophages and SMCs in the DR and AL groups, our data do not support that DR can improve atherosclerotic progression. Considering that humans and rabbits are LDL-enriched mammals and their lipoprotein profile are more similar than mice and rats, the current study may provide a novel insight into the effect of DR on cardiovascular system (Fan et al. 2015) . Moreover, rabbits have greater body size than rodents, facilitating to be evaluated by metabolic indexes such as food consumption, body weight and plasma parameters.
Therefore, the current study also provides valuable information that DR may promote the adverse effect on the cholesterol metabolism, which may finally retard the regression of atherosclerosis when patients with dramatic lipid lowering. Indeed, there were two primate studies also presented the opposite results:
The University of Wisconsin group showed that the DR monkeys had a 50% reduction in cardiovascular disease versus controls, whereas the Wake Forest University group showed that DR group had no improvement in cholesterol, blood pressure, or coronary artery atherosclerosis (Cefalu et al. 2004; Colman et al. 2009 ). Combined to these results, the current study suggests that the benefits of DR may need to be further investigated in the patients with hyperlipidemia or the CVD.
Taken together, the current study has proven that DR can cause the dysfunction of cholesterol metabolism in rabbits with dietary lipid lowering, which may further neutralize the benefits of DR on the CVD. In light of fact that cholesterol and glucose homeostasis are maintained by extremely sophisticated manners in mammals, we conclude that simple DR does not ameliorate atherosclerotic regression in rabbits when associated with lipid lowering by the dietary cholesterol withdrawal. 12 weeks to develop mild atherosclerosis. Then, these rabbits were randomly divided into four groups, and one group (n=10) was sacrificed immediately as the baseline control group and another group was continually fed by HCD in another 16 weeks as a positive control group (n=10). The rest of rabbits were divided into two groups and fed with a normal diet instead of a HCD. Among them, the DR group (n=15) was fed by the dietary restriction and received 60% of the diet consumption in the group that was fed by ad libitum (AL, n=15). D r a f t Fig. 1 A schematic diagram of experimental protocol. 50 Japanese white rabbits were fed by a HCD for 12 weeks to develop mild atherosclerosis. Then, these rabbits were randomly divided into four groups, and one group (n=10) was sacrificed immediately as the baseline control group and another group was continually fed by HCD in another 16 weeks as a positive control group (n=10). The rest of rabbits were divided into two groups and fed with a normal diet instead of a HCD. Among them, the DR group (n=15) was fed by the dietary restriction and received 60% of the diet consumption in the group that was fed by ad libitum (AL, n=15).
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